BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America

  Mr. Beller will join the Nexstim Management Team and report to CEO Martin Jamieson.

  December 1, 2017

   · 

  3 min read
• Drug Development

  VM BioPharma Announces Initiation of Hepatocyte Growth Factor to Improve Functioning in PAD, HI-PAD, Study of VM202 in Peripheral Artery Disease

  VM BioPharma today announced the launch of the HI-PAD study, a trial to investigate the effect of VM202, a DNA plasmid encoding HGF, on mobility and calf perfusion in older adults with PAD.

  December 1, 2017

   · 

  6 min read
• 

  Business

  Basilea Snags Extended $226M+ Antifungal Deal With Pfizer

  Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales.

  December 1, 2017

   · 

  5 min read
• Pharm Country

  Tauriga Sciences Fully Repays $45,000 8% Face Value Convertible Debenture Issued to GS Capital Partners, LLC for One Time Cash Payment of $61,664.79

  This convertible debenture, which was issued by the Company on May 30, 2017, has been fully repaid for a one-time cash payment of $61,664.79 USD.

  December 1, 2017

   · 

  3 min read
• Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch

  The grant, together with contributions from the city and province of Groningen, totals EUR 1.2 million.

  December 1, 2017

   · 

  1 min read
• Skyline Medical Announces the Completion of Private Placement for Gross Proceeds of $1,300,000

  The closing of the private placement occurred on November 28, 2017.

  December 1, 2017

   · 

  5 min read
• Pharm Country

  Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C to ACDF at Seven Years

  SECURE-C long-term data confirms earlier clinical outcomes and maintains superiority.

  December 1, 2017

   · 

  5 min read
• Genetown

  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec. 1, 2017

  The employees received, in the aggregate, options to purchase 29,090 shares of Sarepta’s common stock.

  December 1, 2017

   · 

  1 min read
• STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

  Since the MAH pilot launch, the company has undertaken eight development programs

  December 1, 2017

   · 

  1 min read
• Novocure Receives Reimbursement Approval for Optune in Japan for the Treatment of Newly Diagnosed Glioblastoma

  Optune is a noninvasive, portable device approved in Japan to treat newly diagnosed and recurrent GBM.

  December 1, 2017

   · 

  7 min read